Medical research

Team identifies a molecular mechanism of type 2 diabetes

Type 2 diabetes is a chronic disease in which the body does not produce enough insulin, or does not use it efficiently. It is caused by the combination of a genetic predisposition to obesity, sedentarism and an unhealthy ...

Medications

Empagliflozin improves HbA1c in young people with T2DM

For young people, empagliflozin is associated with improvement in glycated hemoglobin (HbA1c), according to a study published in the March issue of The Lancet Diabetes & Endocrinology.

page 123 from 610